Search

Shimin M Xu

from San Diego, CA
Age ~53
Get Report
Also known as:
Shi Min Xu, Shi M Xu, Shamin Xu, Shi-Min Xu, Shimin Zu, Xu Shi-Min
Phone and address:
16660 Honeybrook Ave, San Diego, CA 92127
Related to:
Eva ShiBang C Xu, 72
Connected to:
Angmai Xu, 69Baoji Xu, 60Baopei Xu, 85Beibei Xu, 40Bingxin Xu, 36Chan Xu, 61Chao Xu, 65Chengkun B Xu, 60Chenxi Xu, 31Chunchun Xu, 34

Shimin Xu Phones & Addresses

  • 16660 Honeybrook Ave, San Diego, CA 92127
  • 11569 Westview Pkwy, San Diego, CA 92126 (805) 376-2677
  • 10676 Dabney Dr #118, San Diego, CA 92126
  • 1690 Camino Olmo #406, Newbury Park, CA 91320 (805) 376-2677
  • Thousand Oaks, CA
  • Goleta, CA
  • Ventura, CA
  • 600 Spring Rd, Moorpark, CA 93021 (805) 531-9267
  • 600 Spring Rd #106, Moorpark, CA 93021 (805) 531-9267

Resumes

Resumes

Shimin Xu Photo 1

Senior Software Engineer In Test

View page
Location:
3393 Octavius Dr, Santa Clara, CA 95054
Industry:
Internet
Work:
Idaptive
Senior Software Engineer In Test
Centrify Corporation Jan 2013 - Dec 2018
Principal Qa Engineer
Authentic8 Dec 2012 - Dec 2013
Senior Software Engineer - Test
Sap Ariba Oct 2010 - Dec 2011
Senior Software Engineer - Test
Sunrun Nov 2009 - Oct 2010
Qa Automation Architect
Education:
University of Michigan 1989 - 1993
Doctorates, Doctor of Philosophy, Chemistry Peking University 1982 - 1986
Bachelors, Bachelor of Science, Chemistry Hengxi High School
Skills:
Agile Methodologies
Testing
Test Automation
Software Quality Assurance
Quality Assurance
Perl
Databases
Java
Scrum
Python
Linux
Xml
Shell Scripting
Selenium
Web Applications
Regression Testing
Unix
Jira
Distributed Systems
Junit
Javascript
Mobile Devices
Subversion
Certifications:
Machine Learning
Introduction To Data Science
An Introduction To Interactive Programming In Python
Creative, Serious and Playful Science of Android Apps
Shimin Xu Photo 2

Senior Director

View page
Location:
San Diego, CA
Industry:
Pharmaceuticals
Work:
Pharmaron Beijing Jun 2012 - Jan 2015
Director
Pharmaron Jun 2012 - Jan 2015
Senior Director
Pharmaron Beijing Nov 2011 - Aug 2012
Senior Investigator
Ambit Biosciences 2008 - 2011
Senior Research Associate
Amgen 1999 - 2007
Senior Associate Scientist
Education:
University of South Florida 1996 - 1999
Tsinghua University 1989 - 1994
Skills:
Drug Discovery
Medicinal Chemistry
Chemistry
Lead Change
Clinical Development
Clinical Trials
Clinical Research
In Vivo
Patents
Sop
Shimin Xu Photo 3

Scientist

View page
Location:
San Diego, CA
Industry:
Pharmaceuticals
Work:
Ab
Scientist

Publications

Us Patents

Calcium Receptor Modulating Agents

View page
US Patent:
6908935, Jun 21, 2005
Filed:
May 22, 2003
Appl. No.:
10/444946
Inventors:
Michael G. Kelly - South San Francisco CA, US
Shimin Xu - Moorpark CA, US
Ning Xi - Thousand Oaks CA, US
Philip Miller - Headington, GB
John F. Kincaid - San Diego CA, US
Chiara Ghiron - Wootton, GB
Thomas Coulter - Wantage, GB
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K031/4439
C07D401/12
US Classification:
514340, 5462764
Abstract:
The compounds of the invention are represented by the following general structure or a pharmaceutically acceptable salt thereof, and compositions containing them, wherein the variables are defined herein, and their use to reduce or inhibit PTH secretion, including methods for reducing or inhibiting PTH secretion and methods for treatment or prophylaxis of diseases associated with bone disorders, such as osteoporosis, or associated with excessive secretion of PTH, such as hyperparathyroidism. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

Substituted Piperidines And Methods Of Use

View page
US Patent:
6977264, Dec 20, 2005
Filed:
Jul 24, 2002
Appl. No.:
10/205649
Inventors:
Christopher H. Fotsch - Thousand Oaks CA, US
Michael Croghan - Thousand Oaks CA, US
Elizabeth M. Doherty - Newbury Park CA, US
Michael G. Kelly - South San Francisco CA, US
Mark H. Norman - Thousand Oaks CA, US
Duncan M. Smith - Thousand Oaks CA, US
Nuria Tamayo - Newbury Park CA, US
Ning Xi - Thousand Oaks CA, US
Shimin Xu - Ventura CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
C07D211/06
A61K031/445
US Classification:
514330, 546226
Abstract:
Selected substituted piperidine compounds are effective for prophylaxis and treatment of diseases, such as obesity and the like. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving activation of the melanocortin receptor. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

Substituted Alkylamine Derivatives And Methods Of Use

View page
US Patent:
6995162, Feb 7, 2006
Filed:
Jan 10, 2002
Appl. No.:
10/046681
Inventors:
Guoqing Chen - Thousand Oaks CA, US
Jeffrey Adams - Thousand Oaks CA, US
Jean Bemis - Arlington MA, US
Shon Booker - Newbury Park CA, US
Guolin Cai - Thousand Oaks CA, US
Lucian Di Pietro - Gloucester MA, US
Celia Dominguez - Thousand Oaks CA, US
Daniel Elbaum - Newton MA, US
Julie Germain - Somerville MA, US
Stephanie Geuns-Meyer - Medford MA, US
Michael Handley - Ventura CA, US
Qi Huang - Moorpark CA, US
Joseph L. Kim - Wayland MA, US
Alexander Kiselyov - Jersey City NJ, US
Xiaohu Ouyang - Flushing NY, US
Vinod F. Patel - Acton MA, US
Leon M. Smith - Somerset NJ, US
Markian Stec - Filmore CA, US
Andrew Tasker - Simi Valley CA, US
Ning Xi - Thousand Oaks CA, US
Shimin Xu - Newbury Park CA, US
Chester Chenguang Yuan - Newbury Park CA, US
Michael Croghan - Ventura CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K 31/435
C07D 213/82
US Classification:
514256, 514300, 514314, 514333, 514336, 514337, 544333, 546113, 546175, 546256, 546262, 5462717, 5462821, 5462827
Abstract:
Selected heterocyclic compounds are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

Substituted Arylamine Derivatives And Methods Of Use

View page
US Patent:
7101868, Sep 5, 2006
Filed:
Apr 12, 2004
Appl. No.:
10/823809
Inventors:
Daniel Elbaum - Newton MA, US
Shon Booker - Thousand Oaks CA, US
Julie Germain - Medford MA, US
Gregory J. Habgood - Merrimac MA, US
Michael Handley - Greenbrae CA, US
Aiwen Li - Westlake Village CA, US
Nobuko Nishimura - West Hills CA, US
Vinod F. Patel - Acton MA, US
Chester Chenguang Yuan - Newbury Park CA, US
Joseph L. Kim - Wayland MA, US
Guolin Cai - Thousand Oaks CA, US
Guoqing Chen - Thousand Oaks CA, US
Michael Croghan - Thousand Oaks CA, US
Lucian V. Di Pietro - Wayland MA, US
Celia Dominguez - Thousand Oaks CA, US
Qi Huang - Moorpark CA, US
Andrew Tasker - Simi Valley CA, US
Ning Xi - Thousand Oaks CA, US
Shimin Xu - Ventura CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K 31/33
A61K 31/44
C07D 211/62
C07D 213/72
US Classification:
514183, 514188, 514277, 514352, 514354, 514356, 546304, 546315, 546345
Abstract:
Selected compounds are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

Substituted Amine Derivatives And Methods Of Use

View page
US Patent:
7105682, Sep 12, 2006
Filed:
Jan 10, 2002
Appl. No.:
10/046622
Inventors:
Guoqing Chen - Thousand Oaks CA, US
Jeffrey Adams - Thousand Oaks CA, US
Jean Bemis - Arlington MA, US
Lucian Di Pietro - Gloucester MA, US
Celia Dominguez - Thousand Oaks CA, US
Daniel Elbaum - Newton MA, US
Julie Germain - Somerville MA, US
Qi Huang - Moorpark CA, US
Joseph L. Kim - Wayland MA, US
Xiaohu Ouyang - Flushing NY, US
Vinod F. Patel - Acton MA, US
Leon M. Smith - Sommerset NJ, US
Andrew Tasker - Simi Valley CA, US
Ning Xi - Thousand Oaks CA, US
Shimin Xu - Newbury Park CA, US
Chester Chenguang Yuan - Newbury Park CA, US
Michael Croghan - Ventura CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
C07D 401/02
A61K 31/44
US Classification:
5462771, 546194, 546199, 5462737, 5462757, 544253, 514255, 514318, 514338, 514339
Abstract:
Selected amines are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

Substituted Piperazinyl Amides And Methods Of Use

View page
US Patent:
7115607, Oct 3, 2006
Filed:
Jul 24, 2002
Appl. No.:
10/202823
Inventors:
Christopher H. Fotsch - Thousand Oaks CA, US
Premilla Arasasingham - Thousand Oaks CA, US
Yunxin Bo - Thousand Oaks CA, US
Ning Chen - Thousand Oaks CA, US
Martin H. Goldberg - Woodland Hills CA, US
Nianhe Han - Thousand Oaks CA, US
Feng-Yin Hsieh - Thousand Oaks CA, US
Michael G. Kelly - Thousand Oaks CA, US
Qingyian Liu - Camarillo CA, US
Mark H. Norman - Thousand Oaks CA, US
Duncan M. Smith - Thousand Oaks CA, US
Markian Stec - Fillmore CA, US
Nuria Tamayo - Newbury Park CA, US
Ning Xi - Thousand Oaks CA, US
Shimin Xu - Moorpark CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K 31/496
C07D 401/12
C07D 403/12
US Classification:
51425213, 51425305, 51425306, 51425313, 51425409, 544359, 544363, 544365, 544373, 544376, 544379
Abstract:
Selected substituted piperazine compounds of Formula I are effective for prophylaxis and treatment of diseases, such as obesity and the like. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving activation of the melanocortin receptor. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

Calcium Receptor Modulating Agents

View page
US Patent:
7176322, Feb 13, 2007
Filed:
May 22, 2003
Appl. No.:
10/444945
Inventors:
Michael G. Kelly - South San Francisco CA, US
Shimin Xu - Moorpark CA, US
Ning Xi - Thousand Oaks CA, US
Robert Townsend - Barnsley, GB
David Semin - Thousand Oaks CA, US
Chiara Ghiron - Wootton, GB
Thomas Coulter - Wantage, GB
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
C07D 209/82
C07D 209/14
C07D 209/04
A61K 31/403
A61K 31/404
A61K 31/4045
US Classification:
548469, 548444, 548503, 548509, 514410, 514411, 514412, 514415
Abstract:
The compounds of the invention are represented by the following general structure.

Calcium Receptor Modulating Agents

View page
US Patent:
7196102, Mar 27, 2007
Filed:
Feb 18, 2005
Appl. No.:
11/061084
Inventors:
Michael G. Kelly - South San Francisco CA, US
Shimin Xu - Moorpark CA, US
Ning Xi - Thousand Oaks CA, US
Philip Miller - Headington, GB
John F. Kincaid - San Diego CA, US
Chiara Ghiron - Wootton, GB
Thomas Coulter - Wantage, GB
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K 31/44
A61K 31/4427
C07D 401/02
C07D 421/02
US Classification:
514336, 514351, 5462681
Abstract:
The compounds of the invention are represented by the following general structure.
Control profile
Shimin M Xu from San Diego, CA, age ~53 Get Report